700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Hung T Khong
|Hung T Khong
Division of Medical Oncology
Huntsman Cancer Institute
University of Utah
Dr. Khong is an Associate Professor in the Division of Medical Oncology at the Huntsman Cancer Institute (HCI) of the University of Utah, where he treats patients and conducts translational research in melanoma, breast cancer, cancer immunotherapy, and targeted therapy. Prior to joining HCI in December of 2011, he was an Associate Professor at the University of South Alabama Mitchell Cancer Institute where he took on various leadership roles including Head of Clinical Immunotherapeutics Research Laboratory and Interim-Chief of Medical Oncology Service, and Associate Director for Clinical Research
Khong specializes in the treatment of melanoma and breast cancer. He has developed several innovative clinical trials for the neoadjuvant treatment of stages II and III breast cancer, first line therapy for metastatic breast cancer, and for advanced or metastatic melanoma.
Khong’s research and clinical interests include cancer immunotherapy and epigenetic modulation in the treatment of cancer. His research focuses on the following:
Adoptive cellular therapy and cancer vaccines (manipulation of the immune system to treat cancer).
Combining treatment methods such as chemo- or radiotherapy with immunotherapy (using the immune system to enhance the effects of chemotherapy and/or radiotherapy).
Chemotherapy with targeted therapy (drugs that intervene with specific molecules involved in tumor growth).
Global Speakers in the subject
Global Experts in the subject